Publication | Closed Access
Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction
54
Citations
19
References
2017
Year
Tocilizumab did not affect CFR during hospitalisation or after 6 months. Tocilizumab increased VCAM-1 levels during hospitalisation, but this was not associated with reduced CFR in these patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1